Synovate Healthcare launches global Oncology capabilities in eight new markets
16 October 2009
NEW YORK — Leading market intelligence company Synovate today announced the expansion of its Global Oncology Monitor in to eight new markets. Previously covering thirteen markets — the US, the UK, Spain, Italy, France, Germany, Poland, Japan, China, South Korea, India, Australia and Taiwan — this monitor now also includes Canada, Mexico, Brazil, Portugal, Russia, Belgium, Turkey and the Netherlands.
"These new markets represent rapidly emerging areas of innovation," said Jackie Ilacqua, Senior Vice President and Head of Global Oncology for Synovate Healthcare. "The addition of these markets to our already comprehensive Oncology Monitor portfolio further cements our position as the leader in global oncology business intelligence."
Oncology therapeutics has been identified as key growth drivers for both pharmaceutical and biotechnology manufacturers. The global oncology drug market is growing exponentially relative to non-oncology pharmaceuticals.
"The tremendous growth in the global oncology therapeutic market is driving the demand for accurate, globally consistent information," said Bob Douglas, Global Head of Synovate Healthcare. "Synovate is uniquely positioned to deliver to that need."
The expansion of Synovate's Global Oncology Monitor will provide clients with much needed insight and visibility into their key cancer markets. "The feedback we received from our pharmaceutical and biotechnology clients revealed there were no reliable patient data resources for these emerging and high-growth markets," said Ilacqua. "With the launch of the Global Oncology Monitors, clients will have access to timely and relevant local market information. They will no longer be 'flying blind' in terms of their product's use or market penetration."
Oncology is the single largest therapy area within Synovate Healthcare. With the launch of these eight new markets, the Global Oncology Monitor provides consistent coverage for twenty-one countries.
Contact(s) for this press release
|
Jackie Ilacqua
Senior Vice President and Executive Director, Global Tandem Oncology Monitor |
|
|
1200 Macarthur Blvd, |
Telephone: +1 201 529 5540 |
Synovate Healthcare is the global specialist healthcare market research arm of Synovate, dedicated to delivering marketing insights to the pharmaceutical and healthcare industries. Synovate Healthcare employs over 500 healthcare market research professionals across Europe, US, Canada, Asia Pacific and Japan and offers syndicated and custom research as well as global fieldwork capabilities.
More information on Synovate Healthcare can be found at www.synovate.com/healthcare.
About Synovate
Synovate generates insights to help clients drive competitive brand, product and customer experience strategies. Now part of Ipsos, with offices in over 80 countries, our approach combines best in class global research capabilities with personalised service, local knowledge and the flexibility to create teams and processes that meet clients' specific requirements. At Synovate, our clients sit at the top of our organisational chart, driving us to continually develop more innovative research solutions that predict actual business outcomes.
For more information on Synovate visit www.synovate.com.